摘要
To explore the mechanisms of Chinese herbal medicine Sanqi Oral Liquid (a parts per thousand eS(a)a aeeiae pound (2)), composed of Astragalus membranaceus and Panpax notoginseng, in alleviating renal injury by observing its effect on the expressions of CD4(+), CD8(+) and CD68(+) cells in 5/6 nephrectomized rats with chronic renal failure. <br>A total of 102 SD rats were randomly divided into six groups: three treatment groups were administrated with high, medium and low dosage of Sanqi Oral Liquid respectively by gavage; a normal group, a 5/6 nephrectomized model group, and a group treated with coated aldehyde oxygenstarch were used as controls. Following oral administration of Sanqi Oral Liquid for 12 weeks, the general condition and renal pathological changes were observed, and the renal function, platelet count (PLT) and the expressions of CD4(+), CD8(+) and CD68(+) cells were determined for each group. <br>There were proliferation of mesangial matrix, renaltubularnecrosis and obvious tubulointerstitial fibrosis in the model group, and they were much milder in the treatment groups. Compared with the model group, the amounts of blood urea nitrogen (BUN), serum creatinine (Scr) and PLT in the treatment groups decreased (P < 0.05 for all); and in the group administrated of medium dosage of Sanqi Oral Liquid, the expression of CD4(+) cells was up-regulated and those of CD8(+) and CD68(+) cells were down-regulated (P < 0.05 for all), leading to an increased ratio of CD4(+)/CD8(+)(P < 0.01). <br>Sanqi Oral Liquid has a significant effect on regulating lymphocyte subsets, reducing the infiltration of macrophages in renal tissues and alleviating tubulointerstitial fibrosis, and this may be one of mechanisms of Sanqi Oral Liquid in delaying the progression of chronic kidney diseases.
学科与关键词
- Sanqi Oral Solution Mitigates Proteinuria in Rat Passive Heymann Nephritis and Blocks Podocyte Apoptosis via Nrf2/HO-1 Pathway (vol 12, 727874, 2021)Wang, Xiaowan; Liu, Jinchu; Tian, Ruimin; Zheng, Bidan; Li, Chuang; Huang, Lihua; Lu, Zhisheng; Zhang, Jing; Mao, Wei; Liu, Bo*; Bao, Kun*; Xu, Peng*Frontiers in Pharmacology, 2022, 13: 905693.
- 三芪口服液对5/6肾切除大鼠肾脏组织中CD4~+、CD8~+及CD68~+细胞表达的影响韦芳宁; 杨霓芝; 陈子林; 杨海峰; 丁海明; 韩凌; 邓时贵; 欧润妹; 欧爱华; 梁燕芬; 胡子衡; 杨小红; 王健2011·中国医师协会中西医结合医师大会论文集.
- 三芪口服液对5/6肾切除大鼠肾组织细胞凋亡的影响韦芳宁; 杨霓芝; 王健; 胡子衡; 丁海明; 杨海峰; 欧爱华; 韩凌; 邓时贵; 欧润妹中国中西医结合肾病杂志, 2011, (03): 239.
